Outcomes after (90)Yttrium-ibritumomab tiuxetan-BEAM in diffuse large B-cell lymphoma: a meta-analysis

High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is a standard therapy in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) who are chemosensitive. The combination of carmustine, etoposide, cytarabine, and melphalan (BEAM) is commonly used as a con...

Descripción completa

Detalles Bibliográficos
Autores principales: Auger-Quittet, Sophie, Duny, Yohan, Daures, Jean-Pierre, Quittet, Philipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303160/
https://www.ncbi.nlm.nih.gov/pubmed/24740968
http://dx.doi.org/10.1002/cam4.247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303160/
https://www.ncbi.nlm.nih.gov/pubmed/24740968
http://dx.doi.org/10.1002/cam4.247

Ejemplares similares